



Biological Characterization of Wild Birds-origin Avian 2 
Avulaviruses 1 and Efficacy of Currently Applied Vaccine against 3 
Potential Infection in Commercial Poultry 4 
 5 
Rania F. El Naggara,b,c , Mohammed A Rohaimb,c,d, AbdelHamid H. Bazida, Kawkab A 6 
Ahmede,, Hussein A. Husseind, Muhammad Munirb,c* 7 
 8 
aDepartment of Virology, Faculty of Veterinary Medicine, University of Sadat City, 32897 9 
Egypt. 10 
bThe Pirbright Institute, Ash Road, Woking, Surrey, GU24 0NF, United Kingdom. 11 
cDivision of Biomedical and Life Science, Lancaster University, LA1 4TB, United Kingdom. 12 
dDepartment of Virology, Faculty of Veterinary Medicine, Cairo University, 12211, Egypt. 13 
eDepartment of Pathology, Faculty of Veterinary Medicine, Cairo University, 12211, Egypt. 14 
 15 
 16 




























Biological Characterization of Wild Birds-origin Avian 43 
Avulaviruses 1 and Efficacy of Currently Applied Vaccine against 44 
Potential Infection in Commercial Poultry 45 
 46 
Abstract 47 
Newcastle disease virus (NDV), a type-specie of Avian Avulaviruses 1 (AAvV-1, formerly 48 
known as avian paramyxovirus serotype 1), causes a highly contagious and economically 49 
important disease in myriad of avian species, around the globe. While extensive vaccination 50 
programs have been implemented in ND-endemic countries, the disease is continuously 51 
spreading in commercial, backyard and wild captive poultry birds. In order to assess the virus 52 
evolution and efficiency of currently applied vaccine regimens in commercial poultry, four 53 
wild birds-origin AAvV-1 strains were biologically characterized through mean death time 54 
and intracerebral pathogenicity index, and were genetically assessed on the basis of cleavage 55 
motif (112RRQKRF117) in the fusion (F) protein. Based on these features, all isolates were 56 
characterized as velogenic strains of AAvV-1. Phylogenetic analysis based on the complete 57 
genome sequences revealed clustering of these isolates within class II, genotype VII. This 58 
class of AAvV-1 remained the most predominant genotype in the Egyptian as well as many 59 
Asian and African poultry industries. To further delineate the potential of these wild-bird’s 60 
origin AAvV-1 isolates in causing infection in domesticated poultry and the efficacy of 61 
currently available vaccines in protecting commercial poultry, an extensive animal challenge 62 
experiments was performed. Cumulative clinicopathological and immunological 63 
investigations in challenged-chickens indicate that these isolates can potentially transmit 64 
between chickens, cause systemic infections, and currently applied vaccines are unable to 65 
prevent clinical disease and virus shedding. Taken together, the data presents a 66 
comprehensive evaluation of Egyptian wild-birds origin AAvV-1 in causing infection in 67 
commercial poultry and highlights the need for a continuous and large-scale surveillance as 68 
well as revised vaccine approaches. These integrated and multifaceted strategies would be 69 
crucial in any efforts to globally control and eradicate the disease.  70 
 71 


















Newcastle disease (ND) is a highly contagious viral disease of both domesticated and wild 88 
bird species, throughout the world [26]. The ND is caused by avian avulaviruses 1 (AAvV-1), 89 
which belong to the genus Avulavirus [6, 21]. All AAvV-1 strains are enveloped and carrying 90 
a genome of approximately 15.0 kilobases, which is negative sense, non-segmented and 91 
single stranded RNA [19]. The genome encodes six linear transcripts for structural (3′-NP-P-92 
M-F-HN-L-5′) proteins, and two additional non-structural transcriptional units (V and W) are 93 
transcribed by the RNA-editing mechanism in the phosphoprotein (P) gene [19].  94 
 95 
Based on the fusion (F) gene sequence, two systems have been developed to classify AAvV-1 96 
isolates into either lineages or classes. The first system classifies AAvV-1 isolates into at 97 
least 6 lineages and 13 sub-lineages [2, 7, 33] whereas the second system divides all AAvV-1 98 
isolates into two distinct classes (I and II) with different genotypic entities. Class I strains are 99 
avirulent and mainly affect wild birds whereas Class II strains can be either virulent or 100 
avirulent and are primarily isolated from wild and domesticated birds [9, 18, 22]. Further 101 
analysis based on the full-length F gene sequences of the AAvV-1 from all lineages and 102 
classes revealed the presence of multiple genotypes in Class I and 18 genotypes in Class II [8, 103 
11, 12, 34]. These genotyping systems provide convincing epidemiological association of 104 
emerging viruses; however, these merely represent any pathological or host association of 105 
AAvV-1. Alternatively, based upon pathogenicity and sequence signature at the protease 106 
cleavage site of the precursor F protein, AAvV-1 strains are commonly categorized into 107 
velogenic, mesogenic and lentogenic pathotypes [3, 32]. Specifically, the amino acid 108 
sequence in velogenic and mesogenic strains is 112R/K-R-Q-R/K-R↓F117, which is cleaved by 109 
a variety of cellular proteases in various organs and thus resulting in systemic infection 110 
(respiratory system, gastro-intestinal tract and nervous system). However, the sequence in 111 
less virulent (lentogenic) strains of AAvV-1 is 112G/K/R-Q-G/ E-R↓L117 [3]. 112 
 113 
Since the expansion of the Egyptian commercial poultry sectors, the ND is causing 114 
devastating losses to the poultry and poses a major threat to the commercial poultry [17, 28]. 115 
In order to effectively control the diseases; mass vaccination programmes have been 116 
implemented in the commercial poultry with limited success [17, 28]. While appropriate 117 
vaccination and subsequent humoral immune responses are key to prevent the disease, this 118 
approach is limited in logistically immunization of both domesticated and wild birds. There 119 
are emerging evidences which dictate the failure of live and/or inactivated vaccines in 120 
protecting birds from current field isolates of AAvV-1 and thus warrant the establishment of 121 
comparative relationship among AAvV-1 isolates being used in vaccines and are reported 122 
from wild bird and commercial poultry [28]. These investigations will establish foundations 123 
to delineate the nature and dynamics of viruses that are causing clinical disease in vaccinated 124 
flocks as well as unvaccinated commercial, and backyard poultry birds. 125 
 126 
Here we completely characterized AAvV-1 strains collected from wild birds across the 127 
Egyptian provinces. Although several reports of disease outbreaks in Egypt [17, 27, 28] are 128 
recorded especially in commercial poultry, these findings mainly focus on partial sequencing 129 
of the F gene, which limits the assessments of evolutionary nature of the virus across the 130 
genome. Owing to recent reports of novel strains of AAvV-1 [6], it is of paramount 131 
importance to establish epidemiological links among adjacent countries and to underline the 132 
risks and challenged to commercial poultry for securing the future food security. To assess 133 
the evolutionary dynamics of these isolates in the Middle East, broad biological and genetic 134 
characterizations were performed, and possible transmission routes of wild bird-origin 135 
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AAvV-1 to the commercial poultry were drawn. Finally, we assessed the potential of 136 
currently applied vaccines against these AAvV-1 to further highlight the risk and 137 
preparedness in disease control in the event of viruses’ jumps from wild birds to commercial 138 
poultry.  139 
 140 
Materials and Methods 141 
 142 
Sampling History, Virus Isolation and Biological Characterization 143 
A total of one hundred-twelve (n=112) cloacal/faecal swabs were collected from different 144 
wild birds from NDV-endemic Egyptian governorates, which are rich in wild bird’s 145 
population and are continuously and frequently affected during 2016 (Table 1 and Table 2). 146 
Capturing and sampling of birds were carried out in accordance with all relevant guidelines, 147 
regulations and animal ethics permits issued by the Faculty of Veterinary Medicine, 148 
University of Sadat City, Egypt and The Pirbright Institute, UK. Individual swabs were 149 
shipped in sterile phosphate-buffered saline (PBS, pH 7.4) supplemented with 50 U/mL 150 
Penicillin–Streptomycin mixture (PenStrep; Lonza). Swabs samples were cleared by 151 
centrifugation for 15 minutes at 2000 rpm at 10 °C and clear supernatants were collected 152 
and stored at −80 °C until further used. 153 
 154 
Virus isolation was carried out in 10-day-old specific pathogen free (SPF) eggs via allantoic 155 
sac inoculation route as described previously [26]. Mean death time (MDT) and intracerebral 156 
pathogenicity indices (ICPI) were calculated according to the reference protocol [26] in 157 
Rhode Island Red SPF chicks. The egg lethal dose 50 (ELD50) was calculated by Reed and 158 
Muench method [29]. Hemagglutination inhibition (HI) assay was performed as previously 159 
described [26, 37] using four hemagglutinating units for LaSota, NDV/Cattle 160 
egret/Egypt/SDU-1/2016 and NDV/Teal/Egypt/SDU-4/2016 and antisera collected from SPF 161 
chickens vaccinated with LaSota (Genotype II) live attenuated and commercial killed vaccine 162 
(Genotype VII). 163 
 164 
Genome Amplification and Sequencing 165 
Total RNA was extracted from the allantoic fluid using RNA extraction kit (QIAamp Viral 166 
RNA Mini Kit, Qiagen, USA) according to the manufacturer’s instructions. Real-time RT-167 
PCR assays targeting the matrix (M) and F genes of AAvV-1 were conducted as described 168 
previously [38]. Positive samples were subjected to conventional RT-PCR in order to amplify 169 
the complete genome of AAvV-1, as described earlier [24]. The amplified PCR products 170 
were purified using PCR Clean-Up System (Promega, Co., Madison, WI) according to the 171 
manufacturer’s instructions and were directly sequenced using ABI PRISM BigDye 172 
Terminator version 3.1 (Applied Biosystems, Foster City, CA). 173 
 174 
Phylogeny and Evolutionary Analysis  175 
Sequences alignment, editing and analyses were performed using BioEdit version 7.0.9.0 176 
[14]. The phylogenetic trees were constructed using the Neighbour-Joining method 177 
implemented in the Kimura-two-parameter model with 1000 bootstrap replicates in 178 
Molecular Evolutionary Genetics Analysis (MEGA) version 6 [35]. Well-known prototype 179 
strains of AAvV-1 were used as representative sequences of each genotype to establish 180 
reliable epidemiological association. Sequences performed in this study were deposited in the 181 
GenBank and are available under the accession numbers MG717683- MG717686. To 182 
estimate the recombination events, AAvV-1 sequence datasets were analysed using RDP 183 
V.3.44. The window size was adjusted to 30 with the highest p value of 0.05. The detection 184 
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of recombination events was applied between sequences sharing 0 and 100 % identity. The 185 
NetNGlyc 1.0 Server was used to predict the potential N-glycosylation sites in the surface F 186 
glycoprotein of isolated strains of AAvV-1 (http://www.cbs.dtu.dk/services/NetNGlyc/). 187 
 188 
Transmission and Challenge experiments.  189 
 190 
Pathobiological assessments of the AAvV-1 in immunized, challenged, mock-infected and 191 
contact birds were performed individually. In the animal experiment, a total of two 192 
representative isolates were chosen to study the pathobiology and possibility of horizontal 193 
transmission of wild bird origin- AAvV-1 to commercial poultry and evaluate the efficacy of 194 
currently used commercial vaccines against isolated AAvV-1. Sixty SPF Rhode Island Red 195 
chicks (kindly provided by the Egyptian SPF Production Farm, Egypt) were housed 196 
separately into two groups; vaccinated (n=20) and non-vaccinated (n=40). These experiments 197 
were conducted in BSL3-compatible isolators in accordance with all relevant guidelines 198 
animal ethics permits issued by the Faculty of Veterinary Medicine, University of Sadat City, 199 
Egypt and The Pirbright Institute, UK. Chicks in non-vaccinated group were divided into 200 
three sub-groups named challenged non-vaccinated (n=20, 10 for each isolate), contact 201 
(n=10, 5 for each isolate) and mock infected (n=10). However, chicks in vaccinated group 202 
(n=20) were kept in two groups of 10 for each isolate (Fig. 1). Following the vaccination 203 
commonly practised by the broiler industry in the country, chicks in vaccinated group were 204 
administered with LaSota vaccine (Genotype II) on day 7 and a subcutaneous injection of a 205 
widely used commercial inactivated vaccine (Genotype VII) on day 12. The lyophilized 206 
vaccine (LaSota, 1000 doses), used for primary immunization, was dissolved in vaccine-207 
provided sterile buffer and administered via eye drops individually to each bird. The 208 
inactivated vaccine was administered with a dose of 0.5 ml per bird via the subcutaneous 209 
route around the neck region. 210 
 211 
Each chick in the vaccinated-challenged and non-vaccinated challenged groups was 212 
inoculated with 100 ul of 106 EID50/ml dose from each isolate through the oculonasal route 213 
on day 28. After 24 h post challenge, the contact birds were kept together with the 214 
vaccinated-challenged birds of each isolate to assess the horizontal transmission of both 215 
viruses (Fig. 1). The mock-infected group served as a negative control and was administered 216 
with a 100ul of sterile normal saline.  217 
 218 
For the next 10 days, birds were monitored twice daily for clinical signs that include 219 
depression, anorexia, sneezing/coughing, facial swelling, respiratory sounds, ocular/nasal 220 
discharge, conjunctivitis, ruffled feathers, reluctance to move, dyspnoea, greenish diarrhoea, 221 
paralysis, tremors, opisthotonus, twisting of head and neck, circling, paresis and or necropsy 222 
lesions from dead chicks that include haemorrhages in proventriculus and caecal tonsils. 223 
Based upon typical necropsy lesions, tissue tropism and histopathology were performed. All 224 
remaining chicks were maintained to observe clinical signs until the end of study period. 225 
Euthanized/dead contact birds were collected every alternative day for necropsy lesions 226 
together with collection of oropharyngeal and cloacal swabs to monitor shedding of the 227 
challenged virus. Likewise, different internal organs were collected from the euthanized/dead 228 
chicks both control and challenged groups for examination of detailed necropsy.  229 
 230 
 231 
Serology, Evaluation of Virus Shedding and Histopathology.  232 
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Sera samples were obtained pre- (day 27) and post-challenge (day 38) from vaccinated-233 
challenged groups and assessed by HI assays. The HI assay was performed using inactivated 234 
NDV antigen according to standard procedures with 4 HAU virus/antigen in 0.025 ml [26]. 235 
Titers were calculated as the highest reciprocal serum dilution providing complete 236 
hemagglutination inhibition. Serum titers of 1:8 (23) or lower were considered negative for 237 
antibodies against NDV. The virus shedding was determined through previously described 238 
assays for identification of velogenic strains of AAvV-1 [38] through oropharyngeal and 239 
cloacal swabs. 240 
 241 
Selected tissues such as whole brain, trachea, lung, liver, kidney, spleen and intestine were 242 
collected and fixed by immersion in 10% neutral buffered formalin at room temperature for 243 
48 h followed by processing and embedding in paraffin wax. Tissue sections of 5 µm were 244 
stained with Haematoxylin and Eosin and examined for microscopic lesions under light 245 
microscope.  246 
 247 
Statistical analysis 248 
Comparison of treated groups was analysed using one-way analysis of variance (ANOVA) 249 
and significant differences among means were tested using a student’s t-test. Kaplan-Meier 250 
analysis was performed to calculate the survival percent. All statistical tests were conducted 251 
in the GraphPad Prism 7 (GraphPad Software, La Jolla, CA, USA). For all assays and 252 
comparisons, the difference was considered significant at a p value of <0.05. 253 
Results 254 
Prevalence of AAvV-1 in different Egyptian provinces, Biological characterization and 255 
Genetic Diversity of Egyptian Wild bird-origin AAvV-1 strains 256 
A total of 112 samples were individually screened by RT-qPCR targeting the M and F genes, 257 
followed by complete genome amplifications for positive samples. From this screen, 3.6 258 
percentage positivity (4 out of 112) was detected among all tested tracheal and faecal/cloacal 259 
samples. We classified all species that were included in the analysis into four different 260 
families that reflected both their taxonomy and their ecology. These families were 261 
Passeridae, Phasianidae, Anatidae and Ardeidae. The Anatidae family was the most 262 
frequently AAvV-1-infected family followed by Phasianidae and Ardeidae, whereas 263 
Passeridae was found negative (Table 1). Furthermore, there were notable variations in the 264 
proportion of positive samples between provinces; Sharqia, Kafr El Sheikh, Gharbia, 265 
Qalubia, Menofia, Giza and Fayoum. The lowest prevalence rates were observed in Kafr El 266 
Sheikh and Giza whereas Fayoum and Sharqia had the highest rates while no positive 267 
samples were detected in Gharbia, Qalubia and Menofia as shown in Table 2. Four positive 268 
AAvV-1 strains reported in this study were subjected to pathogenicity index using SPF 269 
chicks, which were 1.6 for NDV/Cattle egret/Egypt/SDU-1/2016, 1.79 for 270 
NDV/Quail/Egypt/SDU-2/2016, 1.83 for NDV/Teal/Egypt/SDU-3/2016 and 1.72 for 271 
NDV/Teal/Egypt/SDU-4/2016 per eight days observation period. Mean death time (MDT) 272 
was 63.2h for NDV/Cattle egret/Egypt/SDU-1/2016, 64.1h for NDV/Quail/Egypt/SDU-273 
2/2016, 65.0h for NDV/Teal/Egypt/SDU-3/2016 and 63.8h for NDV/Teal/Egypt/SDU-4/2016 274 
indicating the velogenic nature for these isolates.  275 
The genome lengths of the reported isolates in this study followed the ‘rule-of-six’, which is 276 
considered the essential feature for efficient replication of paramyxoviruses [19]. Annotation 277 
of the genome indicate that the entire length of isolated viruses encodes transcriptional units 278 
for 3’-N-P-M-F-HN-L-5’ as expected for AAvV-1. The percentage nucleotide identity 279 
between the studied isolates ranged between 97.5% and 99%, and these isolates revealed a 280 
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varying degree of genetic diversity with other representative genotypes of AAvV-1. Four 281 
isolates showed multiple basic amino acid residues at the cleavage site (F0) of the F protein 282 
that are characteristic features for mesogenic/velogenic strains of AAvV-1 [19]. The 283 
consistent residues 112R-R-Q-K-R116 with phenylalanine at position 117 (116↓F117) were found 284 
at the F2 protein and the NH2-terminus of the F1 protein. Previous studies have reported six 285 
potential glycosylation sites in the F protein, which are highly conserved in most AAvV-1 286 
genotypes. The glycosylation motif of Asn-X-Ser/Thr [(N-X-S/T, where X could be any 287 
residue except proline (P) and aspartic acid (D)] was identified in the studied isolates. These 288 
sites include 85N-R-T87, 191N-N-T193, 366N-T-S368, 471N-N-S473 and 541N-N-T543. 289 
The transmembrane region (aa from 501-521) in the F protein of four isolates, characterized 290 
in this study, showed several substitutions (summarized in the Table 3). Interestingly, four 291 
isolates carried three substitutions in the fusion peptide. However, amino acid substitutions in 292 
the fusion peptide and heptad repeat region (HR) region (Table 3) can affect the fusogenic 293 
activity of the F protein [5, 9, 30].  Similarly, differences in amino acid length of the HN 294 
protein have been reported previously from different strains of AAvV-1 [30]. However, 295 
isolates in the current study carried an ORF (1716 bp) encoding 571 residues; a feature 296 
common to most of the virulent AAvV-1 [25, 30]. In the transmembrane domain of the HN 297 
protein (25-45 aa), there were seven amino acid substitutions which were prominent within 298 
NDV/Cattle egret/Egypt/SDU-1/2016 isolate, nine substitutions within 299 
NDV/Quail/Egypt/SDU-2/2016 isolate and six substitutions within NDV/Teal/Egypt/SDU-300 
3/2016 and NDV/Teal/Egypt/SDU-4/2016 (Table 3). Analysis of the neutralizing epitopes in 301 
the HN protein identified a total of four amino acid substitutions, which are important in the 302 
formation of antigenic epitope and could result in neutralizing escape variants [16]. AAvV-1 303 
isolates, reported in this study, carried five potential N-glycosylation sites, key residues for 304 
receptor binding and crucial amino acids in the hydrophobic core of the stalk 4HB [16, 40] 305 
(Table 3).  306 
 307 
To determine the epidemiological clustering of isolates in the current study with the AAvV-1, 308 
all available complete genomes from National Centre for Biotechnology Information (NCBI) 309 
databases were downloaded and used for the phylogenetics and comparative genomics. To 310 
further enrich the datasets with Egyptian isolates, all available Egyptian AAvV-1 sequences 311 
in the NCBI databases were considered for epidemiological assessment of isolates. The 312 
Bayesian consensus phylogenetic analysis, verified by the Neighbour-Joining method, clearly 313 
divided the AAvV-1 strains into six lineages, and the four reported isolates in this study 314 
clustered with isolates of Lineage 5 (Genotype VII) in association with strains reported 315 
previously from Egypt and China (Fig 2a). The clustering pattern of selected isolates within 316 
Lineage 5/Genotype VII at a higher resolution (Fig 2b), showed their close association within 317 
their sub-genotypes/sub-lineages. Based on sequence comparison, four isolates showed 318 
higher than 15% nucleotide difference compared to routinely used vaccines in the country 319 
[LaSota (Genotype II) and Avinew (Genotype I)].  320 
 321 
Horizontal transmission, virus-host relationships, and Efficacy of the commercially 322 
available vaccines (LaSota and Genotype VII inactivated). 323 
The protective efficacy of commonly used commercial vaccines (LaSota and inactivated 324 
vaccines) were assessed against wild bird originated AAvV-1, as outlined in Fig. 1.  325 
Moreover, it is important to investigate the infectious nature of isolates that are originated 326 
from non-chicken hosts but cluster within the group of AAvV-1 that are reported from 327 
domesticated chickens. Moreover, HI assay was carried out for both Cattle egret/Egypt/SDU-328 
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1/2016 and Teal/Egypt/SDU-4/2016 isolates using sera collected from SPF chicks immunised 329 
with commercial LaSota and an inactivated vaccine. However, as was expected, a lower 330 
cross-reactivity was observed between the sera collected from LaSota and inactivated vaccine 331 
immunized chicks in relation to both isolates (Fig 3a). 332 
 333 
Shedding of virus was detected using RT-qPCR in contact groups challenged with Cattle 334 
egret/Egypt/SDU-1/2016 and Teal/Egypt/SDU-4/2016 isolates from day 6 to 10 in 335 
comparison with mock-inoculated chicks that revealed no virus detection throughout the 336 
experiment. Cloacal and oropharyngeal swabs were collected at every alternate day (on 2, 4, 337 
6, 8 and 10 days) until the end of the experiment. Viral shedding in cloacal swabs was 338 
identified in both isolates, on day 4 post-challenge in vaccinated-challenged group with 339 
Cattle egret/Egypt/SDU-1/2016 while it was detected on day 6 post-challenge in vaccinated-340 
challenged group with Teal/Egypt/SDU-4/2016. However, virus shedding was detectable in 341 
contact chicks from day 6–10 in Cattle egret isolate while in Teal-isolate from day 8-10. 342 
Nevertheless, we found lack of shedding through cloaca route in contact birds challenged 343 
with Teal-isolate on day 6.   344 
   345 
Likewise, observed clinical signs for AAvV-1 started to appear in both non-vaccinated 346 
challenged groups on the 4th day post-challenge/virus-inoculation that include depression, 347 
anorexia, mild respiratory sounds and oculonasal discharge. Interestingly, all chicks in both 348 
non-vaccinated challenged groups died on day 7 and 8 post infection for Cattle egret and Teal 349 
isolates, respectively due to severe neurological disease (Fig 3b and 3c). Kaplan-Meier 350 
analysis has been performed which revealed that the protective effect of the vaccine on 351 
chick’s survival was statistically significant with P- value < 0.0001 that indicate partial cross 352 
protection to the challenged viruses at which the survival percentage was 40% for vaccinated 353 
challenged group with Cattle egret/Egypt/SDU-1/2016 and 60% for vaccinated challenged 354 
group with Teal/Egypt/SDU-4/2016. The nervous signs were also prominent in the 355 
vaccinated challenged groups before death, potentially indicating lack of complete protection 356 
induced by vaccination. Although severity of clinical signs such as twisting of the head and 357 
neck, circling movement and opisthotonus was more often observed in chicks challenged 358 
with the virulent Cattle egret isolate, the disease outcome coupled with the post-mortem 359 
AAvV-1 pathognomonic lesions that were observed on day 7 post-challenge. Pathogenicity 360 
of isolates showed typical gross necropsy lesions of AAvV-1. Various tissues were collected 361 
from dead chicks that revealed typical necropsy lesions compared to mock-infected negative 362 
control group.  363 
Sera samples were collected from survived birds in both challenged-vaccinated groups on day 364 
38 (day 10 post-infection) and HI assay was conducted. The antibody titres to immunizing 365 
LaSota strain, killed vaccine and the respective challenge virus were compared as pre-366 
challenge (day 27) versus post-challenge (day 38) immune response (Fig 3d). We observed 367 
an increased immune titre, which was statically non-significant with p-value= 0.6 (based on 368 
Student’s t-test) between two challenged vaccinated groups. Birds challenged with Cattle 369 
egret/Egypt/SDU-1/2016 isolate showed GMT 10.7, while it was 9.3 in birds challenged with 370 
the Teal-isolate (Fig 3d). This increase in post-challenge antibody titres may be due to the 371 
replication of the challenged viruses in both groups and partial cross-reactivity to vaccine 372 
strains. 373 
 374 
The microscopic changes were relatively less profound in chicks challenged with 375 
Teal/Egypt/SDU-4/2016 isolate compared to Cattle egret/Egypt/SDU-1/2016 isolate. Both 376 
strains caused detectable histopathological lesions including congestion of blood vessels in 377 
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the lamina propria associated with moderate oedema in the lamina propria/submucoas layer 378 
(Fig 4). Severe histopathological alterations were noticed in the lung of chickens infected 379 
with Cattle egret/Egypt/SDU-1/2016 isolate, congestion of blood vessels, focal pulmonary 380 
haemorrhage, pneumonia described by infiltration of the air capillaries with inflammatory 381 
exudate (mainly mononuclear inflammatory cells) as well as focal pulmonary emphysema. 382 
Likewise, marked fibrinoid necrosis, lymphocytic necrosis and depletion were noticed in the 383 
spleen. Caecal tonsils revealed massive heterophils infiltrating the lamina propria with 384 
lymphocytic necrosis and depletion. Examined liver revealed Kupffer’s cells activation, 385 
dissociation of hepatic plates, cytoplasmic vacuolization of hepatocytes as well as focal 386 
hepatic necrosis and apoptosis with inflammatory cells infiltration and hyperplasia of biliary 387 
epithelium and fibroplasia in the portal triad. Lesions in brain revealed congestion of the 388 
cerebral blood vessels, neuronal oedema, perivascular oedema, necrosis of neurons and 389 
neuronophagia of necrotic neurons (Fig 4). 390 
 391 
Discussion 392 
The Egyptian poultry industry has experienced enormous economic losses due to continuous 393 
outbreaks of velogenic ND in different sectors of commercial poultry industry. It has been 394 
proposed that increased genetic divergence between field strains and vaccine may be 395 
responsible for disease outbreaks in vaccinated flocks due to non/partial-protective immune 396 
induction be the vaccine strains [23]. Since wild birds are known to be natural reservoir of 397 
AAvV-1, viruses of low virulence could emerge as velogenic AAvV-1 that carry mutation in 398 
the F0 cleavage site [2, 4, 10]. Moreover, phylogenetically related AAvV-1 of class II, 399 
possibility causing disease outbreaks, have been isolated from wild birds [22]. Due to these 400 
complications, it is imperative to investigate the evolutionary dynamic of field AAvV-1 401 
strains together with their potential pathobiology in vaccinated and non-vaccinated poultry 402 
birds. The genotype VII represents the most prevalent group of AAvV-1 in the Middle East 403 
countries and all AAvV-1 isolated from wild birds mostly belong to genotype VII [18]. In 404 
this study, four AAvV-1 isolates from different wild birds were classified into genotype 405 
VII/lineage 5. Analysis of the deduced residues at the cleavage site of characterized isolates 406 
in the current study and previously reported isolates from Egypt [17, 27, 28] indicated a high 407 
prevalence, and circulation of genotype VII of AAvV-1 in the country. 408 
 409 
While assumptions can be drawn based on the cleavage site and biological characterization, 410 
pathobiology of these isolates has not been studied in animal challenge experiments. 411 
Biological characterization revealed mean death time (ranged from 63.2 to 65 h), whereas 412 
genetic characterization (112RRQKRF117) confirmed the virulent nature of these isolates. 413 
Furthermore, comparative analysis of functional domains of F and HN proteins of studied 414 
isolates highlight evolutionary constrains on the F protein compared to other representative 415 
velogenic genotypes and vaccine strain. Since the neutralization antibodies raised against the 416 
F protein define the protection status of the host, these modifications in the F protein explain 417 
the potential of immune escape and lack of sterile immunity caused by currently available 418 
vaccines. Moreover, the substitutions particularly in the fusion peptide, hydrophobic regions 419 
and transmembrane region of the F protein and neutralizing epitopes of the HN protein could 420 
result in altered fusion activity and neutralizing escape variants [14, 15, 37]. Taken together, 421 
nucleotide and subsequent amino acid substitutions explained the evolving nature of RNA 422 
viruses including the AAvV-1 however warrant future investigation to delineate the 423 




Phylogenetic analysis of the complete genome and hypervariable region of the F gene of wild 426 
bird-originated AAvV-1 revealed evolutionary relationships to lineage 5/genotype VII, which 427 
is predominantly among the Egyptian poultry sectors. The findings of this study provide 428 
genetical and clinicopathological characterization of wild bird-originated AAvV-1 in Egypt. 429 
Four studied isolates, NDV/Cattle egret/Egypt/SDU-1/2016, NDV/Quail/Egypt/SDU-2/2016, 430 
NDV/Teal/Egypt/SDU-3/2016 and NDV/Teal/Egypt/SDU-4/2016, clustered within lineage 431 
5/genotype VII and were found to be closely related to isolates previously reported from 432 
Egyptian domesticated chickens. Lineage 5/genotype VII is thought to have originated from 433 
the Far East with the first isolation from Taiwan in the 1980s [39]. Since then, there have 434 
been detections of this genotype in various parts of the world [2]. A number of velogenic 435 
AAvV-1 strains, with variable genetic diversity at the sub-lineage level, have been reported 436 
from several Middle East countries [13]. Results presented here demonstrate the 437 
predominance of lineage 5/genotype VII, which highlight the risk of genotype VII 438 
transmission among different avian hosts. 439 
Since there is only one reported serotype for all AAvV-1, lentogenic strains (e.g. LaSota or 440 
B1) are being used as live-attenuated vaccine to protect birds from velogenic NDVs. These 441 
classic vaccines are known to prevent disease but not infection; replication and shedding of 442 
the virus occur even in vaccinated animals. Due to the increasing wave of ND outbreaks since 443 
2010, killed vaccines from genotype VII have been included into the vaccination schedule in 444 
ND-endemic countries including Egypt [17, 27, 28]. Owing to the fact that the vaccine strains 445 
belong to genotype II, which were isolated approximately 60–70 years ago and that most of 446 
the circulating Egyptian strains are clustered within genotype VII, it is likely that the genetic 447 
distances reflect antigen differences and may result in lack of complete protection against 448 
field viruses and shedding of virulent AAvVs in the environment.  449 
 450 
In the assessment of the clinicopathological impact of two representative isolates, we 451 
observed sudden deaths in challenged non-vaccinated chicks, which was expected, as death 452 
with no apparent clinical indications is considered the most noteworthy evidence of velogenic 453 
NDVs. Similar observations have been reported by Samuel et al. [31] in immunologically 454 
naive birds challenged with virulent isolates of African origin. Although severity of observed 455 
neurological clinical signs was relatively less for Teal/Egypt/SDU-4/2016 isolate than Cattle 456 
egret/Egypt/SDU-1/2016 isolate, the morbidity, mortality and virus shedding were 457 
comparable between these groups. Interestingly, the nervous signs were prominent in the 458 
vaccinated group, potentially indicating lack of complete protection induced by the vaccine. 459 
Viral shedding together with increase in antibody titre suggests that the commonly practised 460 
vaccine schedule and vaccine types (LaSota and killed vaccine of genotype VII) give partial 461 
protection from disease, and are unable to protect from infection and virus replication, at least 462 
in laboratory experiments. Moreover, a lower HI was observed between sera collected from 463 
LaSota and inactivated vaccine-immunized SPF chicks against Cattle egret/Egypt/SDU-464 
1/2016 and Teal/Egypt/SDU-4/2016 isolates. These findings further highly a lack of complete 465 
neutralization potential of vaccines strains against the field strains. 466 
 467 
Taken together, genetic differences observed in the functional domains and neutralization 468 
epitopes of the F and HN proteins of wild bird origin isolates in compare to the vaccine 469 
strains could be attributed to increased virulence and vaccine escape mutants [1]. These 470 
results may be useful in revising and/or updating the vaccine schedule being currently 471 
practised in Egypt and other ND-endemic countries. Furthermore, it ascertains the need to 472 
establish and maintain active and passive surveillance for AAvV-1 in wild birds and to expect 473 
11 
 
increased disease emergence in case close interaction occurs between AAvV-1-positive wild 474 
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Figures captions 713 
 714 
715 
Fig. 1. Experimental plan for the assessment of virus infectivity and vaccine effectiveness 716 




Fig. 2. 719 
Phylogenetic analysis of studied isolates and their clustering patterns with representative 720 
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AAvVs-1. (a) Complete genome-based phylogenetic analysis of four wild bird origin AAvV 721 
isolates with the representative strains of each lineage/genotype in class I and class II 722 
reported elsewhere in the world. (b) Full length F gene based phylogenetic analysis of four 723 
wild bird origin AAvV isolates with the representative strains of each genotypes. Reported 724 
isolates clustered in the lineage 5/genotype VII of class II. Position of clustering is marked 725 
with blue arrow. 726 
 727 
Fig. 3. Serological monitoring and survival curves for studied isolates. (a) Haemagglutination 728 
inhibition assay based cross reactivity between wild bird’s origin AAvVs-1 in relation to 729 
antibodies from vaccinated SPF chicks with LaSota and commercial inactivated vaccine 730 
(genotype VII). Results indicate that low HI of wild bird origin AAvVs-1 (Cattle 731 
egret/Egypt/SDU-1/2016 and Teal/Egypt/SDU-4/2016 isolates) with commercial vaccine 732 
19 
 
(Lasota and Inactivated) in compare to Lasota antigen. (b) Percentage survival rates of 733 
vaccinated-challenged group (40%), non-vaccinated challenged (positive control) with Cattle 734 
egret isolate, contact (non-vaccinated and immunologically naive) (70%) and negative 735 
control groups. using one-way analysis of variance (ANOVA), P<0.0001. (c) Percentage 736 
survival rates of vaccinated challenged group (60%), non-vaccinated challenged (positive 737 
control) with Teal/Egypt/SDU-4/2016 isolate, contact (80%) and negative control groups. 738 
using one-way analysis of variance (ANOVA), P<0.0001. (d) Comparison of pre- and post-739 
challenge sero-conversion of sera (GMT) samples in chicks that were immunized with 740 
LaSota and killed vaccine. Sera were taken prior to challenge on day 27 and post-challenge 741 
on day 38. Significant differences among means were tested using a student’s t-test whereas 742 
P=0.6 743 
 744 
Fig. 4. Microscopic examination of different tissues collected from chicken infected with 745 
Cattle egret/Egypt/SDU-1/2016 and Teal/Egypt/SDU-4/2016 isolates. Arrows indicate 746 
lesions in the affected tissues. (G,H,I,J,K and L) histopathological lesions in different tissues 747 
collected from chicks which were infected with Cattle egret isolate. (G) Congestion of blood 748 
vessels, focal pulmonary hemorrhage, pneumonia described by infiltration of the air 749 
capillaries with inflammatory exudate (mainly mononuclear inflammatory cells). (H) Focal 750 
necrosis of the mucosa (small arrow) and edema in the propria/submucosal layer. (I) 751 
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Lymphocytic necrosis lymphocytic depletion and marked fibrinoid necrosis. (J) Kupffer cells 752 
activation (small arrow), and portal infiltration with few inflammatory cells (large arrow). (K) 753 
Perivascular edema. (L) Massive heterophils infiltrating lamina propria. (M,N,O,P,Q and R) 754 
Histopathological lesions in chicken tissues infected with Teal/Sharkia/Egypt/VRLCU/2016. 755 
(M) Pulmonary haemorrhage. (N) Inflammatory cells infiltration in thepropria/submucosal 756 
layer. (O) Lymphocytic necrosis, lymphocytic depletion and marked fibrinoid necrosis. (P) 757 
Focal hepatic necrosis associated with mononuclear cells infiltration. (Q) Perivascular cuffing 758 
with mononuclear cells. (R) Lymphocytic necrosis and depletion. (A,B,C,D,E and F) 759 
Histology of normal tissues: liver, kidney, caecal tonsil, trachea, lung and small intestine 760 
collected from the mock-infected group. 761 
 762 
